Mano Yuji, Usui Takashi, Kamimura Hidetaka
Drug Metabolism Research Laboratories, Astellas Pharma Inc, 1-8, Azusawa 1-Chome, Itabashi-ku, Tokyo, 174-8511, Japan.
Pharm Res. 2006 Jul;23(7):1502-8. doi: 10.1007/s11095-006-0250-5. Epub 2006 Jun 21.
To assess the uridine diphosphate (UDP)-glucuronosyltransferase (UGT) isozymes involved in the glucuronidation of niflumic acid in human liver.
The glucuronidation activity of niflumic acid was determined in liver microsomes and recombinant UGT isozymes by incubation of niflumic acid with UDP-glucuronic acid (UDPGA).
Incubation of niflumic acid with liver microsomes and UDPGA produced one peak, which was identified as a glucuronide from mass spectrometric analysis. A study involving a panel of recombinant human UGT isozymes showed that glucuronidation activity was highest in UGT1A1 among the isozymes investigated. The glucuronidation in human liver microsomes (HLMs) followed Michaelis-Menten kinetics with a Km value of 16 microM, which is similar to that found with recombinant UGT1A1. The glucuronidation activity of niflumic acid in microsomes from eight human livers significantly correlated with UGT1A1-catalyzed estradiol 3beta-glucuronidation activity (r=0.78, p<0.05). Beta-estradiol inhibited niflumic acid glucuronidation with an IC50 of 25 microM in HLMs, comparable to that for UGT1A1.
These findings indicate that UGT1A1 is the main isozyme involved in the glucuronidation of niflumic acid in the human liver.
评估参与人体肝脏中尼氟酸葡萄糖醛酸化反应的尿苷二磷酸(UDP)-葡萄糖醛酸基转移酶(UGT)同工酶。
通过将尼氟酸与UDP-葡萄糖醛酸(UDPGA)孵育,测定肝脏微粒体和重组UGT同工酶中尼氟酸的葡萄糖醛酸化活性。
尼氟酸与肝脏微粒体和UDPGA孵育产生一个峰,经质谱分析鉴定为葡萄糖醛酸苷。一项涉及一组重组人UGT同工酶的研究表明,在所研究的同工酶中,UGT1A1的葡萄糖醛酸化活性最高。人肝脏微粒体(HLMs)中的葡萄糖醛酸化遵循米氏动力学,Km值为16微摩尔,这与重组UGT1A1的情况相似。来自八个人肝脏的微粒体中尼氟酸的葡萄糖醛酸化活性与UGT1A1催化的雌二醇3β-葡萄糖醛酸化活性显著相关(r = 0.78,p < 0.05)。β-雌二醇在HLMs中以25微摩尔的IC50抑制尼氟酸葡萄糖醛酸化,与UGT1A1的情况相当。
这些发现表明UGT1A1是参与人体肝脏中尼氟酸葡萄糖醛酸化的主要同工酶。